Vimarsana
Biggest News Aggregation in the World

Page 5 - Immunization Practices News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immunization Practices. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immunization Practices Today - Breaking & Trending Today

US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021 | Vaccination | JAMA - Vimarsana News

US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021 | Vaccination | JAMA

This study describes the reported US cases of cerebral venous sinus thrombosis (CVST) with thrombocytopenia following vaccination with Ad26.COV2.S, the

Governor Walz: Minnesota Ready to Vaccinate 12-15-Year-Olds This Week as FDA Gives Pfizer Authorization - Vimarsana News

Governor Walz: Minnesota Ready to Vaccinate 12-15-Year-Olds This Week as FDA Gives Pfizer Authorization

[ST. PAUL, MN] — Following the Food and Drug Administration’s authorization of Pfizer/BioNTech's COVID-19 vaccine for 12-to-15-year-olds today, Governor Tim Walz announced that Minnesota is ready to begin vaccinating this

HHS Releases New Data Showing Over 10 Million People with Medicare Received a Free Vaccine Because of the President's Inflation Reduction Act; Releases Draft Guidance for the Second Cycle of Medicare Drug Price Negotiation Program - Vimarsana News

HHS Releases New Data Showing Over 10 Million People with Medicare Received a Free Vaccine Because of the President's Inflation Reduction Act; Releases Draft Guidance for the Second Cycle of Medicare Drug Price Negotiation Program

Over 10 million people with Part D Medicare received a free vaccine thanks to the Inflation Reduction Act, up from just 3 million in 2021.

Source: hhs.gov
Real-World Evidence Shows 82% Reduction in Infant RSV Hospitalizations With Nirsevimab - Vimarsana News

Real-World Evidence Shows 82% Reduction in Infant RSV Hospitalizations With Nirsevimab

The results reinforce other real-world evidence from several broad infant immunization programs in the US, Spain, and France.

Updated 2023-2024 COVID-19 Vaccine Recommended for Immunocompromised Adults - Vimarsana News

Updated 2023-2024 COVID-19 Vaccine Recommended for Immunocompromised Adults

The updated 2023-2024 COVID-19 vaccine conferred increased protection against COVID-19-related hospitalization in immunocompromised adults.